A retrospective, multicenter study of ibrutinib in patients with relapsed/refractory mantle-cell-lymphoma
Latest Information Update: 02 Aug 2016
At a glance
- Drugs Ibrutinib (Primary)
- Indications Mantle-cell lymphoma
- Focus Therapeutic Use
- 02 Aug 2016 New trial record
- 07 Jun 2016 Results presented at the 52nd Annual Meeting of the American Society of Clinical Oncology